Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Global - Adult and Child Deaths due to AIDS (Million), 1990-2009
Figure 3-2: Global - Number of People Newly Infected with HIV (Million), 1990-2009
Figure 3-3: Global - HIV/AIDS Treatment Coverage in Low and Middle Income Countries (%), 2009
Figure 3-4: Global - HIV/AIDS Therapeutics Market (Billion US$), 2010-2014
Figure 4-1: Global - Atripla Sales (Billion US$), 2007-2010
Figure 4-2: Global - Truvada Sales (Billion US$), 2007-2010
Figure 4-3: Global - Kaletra Sales (Billion US$), 2007-2010
Figure 4-4: Global - Reyataz Sales (Billion US$), 2007-2010
Figure 4-5: Global - Fuzeon Sales (Million US$), 2009 & 2010
Figure 4-6: Global - Sustiva Sales (Billion US$), 2007-2010
Figure 5-1: US - Key HIV/AIDS Products Sales (Million US$), 2010
Figure 5-2: US - HIV/AIDS Therapeutics Market (Billion US$), 2010-2014
Figure 5-3: US - Federal Funding for HIV/AIDS (Billion US$), FY 2009 to FY 2012
Figure 5-4: US - Forecast for Federal Funding in HIV/AIDS by Category (%), FY 2012
Figure 5-5: EU - Number of AIDS Cases by Geographical Area (per ‘00,000 Population), 2004-2009
Figure 5-6: EU - HIV/AIDS Therapeutics Market (Billion US$), 2010-2014
Figure 5-7: Japan - Number of New HIV and AIDS Cases (1985-2008)
Figure 5-8: Japan - HIV/AIDS Therapeutics Market (Million US$), 2010-2014
Figure 5-9: Japan - Funding for HIV/AIDS by Category (%)
Figure 8-1: Global - HIV Spending in Low and Middle Income Countries (Billion US$), 2006-2008
Figure 8-2: Global - R&D Investment in HIV Treatment by Research Area (%), 2009
Figure 8-3: Global - Investment in HIV/AIDS Drug Discovery & Development by Area (%), 2009
Figure 8-4: Global - R&D Investment in HIV Treatment by Sector (%), 2009
Figure 9-1: GSK - Breakup of HIV/AIDS Product Sales (%), 2010
Figure 9-2: Merck - HIV/AIDS Drug Sales (Million US$), 2009 & 2010

List of Tables:

Table 3-1: Global - Key HIV/AIDS Statistics by Region (2001 & 2009)
Table 5-1: US - Key HIV/AIDS Statistics
Table 5-2: EU - Key HIV/AIDS Statistics by Geographical Area (2009)
Table 6-1: Global - Antiretroviral Compounds in Pipeline